Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Synthesis of paricalcitol: A novel strategy combining chemical and microbial transformations

Abstract

A novel strategy was developed for the preparation of paricalcitol (1α,25-dihydroxy-19-norvitamin D2) via seven-step chemical transformation and one-step microbial transformation. Using vitamin D2 as a starting material, 1α- and 25-hydroxyl groups of paricalcitol were introduced by Pseudonocardia autotrophica CGMCC5098 at the late stage of the synthesis, allowing us to avoid harsh reaction conditions and tedious steps. The overall yield of paricalcitol was 0.75%.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Fraser, D.R. and Kodicek, E., Nature, 1970, vol. 228, pp. 764–766.

  2. 2.

    DeLuca, H.F. and Schnoes, H.K., Annu. Rev. Biochem., 1983, vol. 52, pp. 411–439.

  3. 3.

    Ikekawa, N., Med. Res. Rev., 1987, vol. 7, pp. 333–366.

  4. 4.

    DeLuca, H.F., Vitamin D, 2nd ed., Feldman D., Pike, J.W., and Glorieux, F.H., Eds., New York: Academic Press, 2005.

  5. 5.

    Noboru, K., Curr. Bioact. Compd., 2006, vol. 2, pp. 301–315.

  6. 6.

    Kubodera, N., Molecules, 2009, vol. 14, p. 3869.

  7. 7.

    Sintov, A. C., Yarmolinsky, L., Dahan, A., and Ben-Shabat, S., Drug Discov. Today, 2014, vol. 19, pp. 1769–1774.

  8. 8.

    Jones, G., Annu. Rev. Nutr., 2013, vol. 33, pp. 23–44.

  9. 9.

    Kulesza, U., Sigüeiro, R., Mouriño, A., and Sicinski, R. R., J. Org. Chem., 2013, vol. 78, pp. 1444–1450.

  10. 10.

    Kabat, M. M. and Radinov, R., Curr. Opin. Drug Discov. Dev., 2001, vol. 4, pp. 808–833.

  11. 11.

    Goldenberg, M. M., Clin. Ther., 1999, vol. 21, pp. 432–441.

  12. 12.

    Trillini, M., Cortinovis, M., Ruggenenti, P., Reyes Loaeza, J., Courville, K., Ferrer-Siles, C., Prandini, S., Gaspari, F., Cannata, A., Villa, A., Perna, A., Gotti, E., Caruso, M. R., Martinetti, D., Remuzzi, G., and Perico, N., J. Am. Soc. Nephrol., 2015, vol. 26, pp. 1205–1214.

  13. 13.

    Bover, J., DaSilva, I., Furlano, M., Lloret, M. J., Diaz-Encarnacion, M.M., Ballarin, J., and Cozzolino, M., Curr. Vasc. Pharmacol., 2014, vol. 12, pp. 313–323.

  14. 14.

    Toyoda, A., Nagai, H., Yamada, T., Moriguchi, Y., Abe, J., Tsuchida, T., and Nagasawa, K., Tetrahedron, 2009, vol. 65, pp. 10002–10008.

  15. 15.

    Kubodera, N., J. Syn. Org. Chem. Jpn., 2010, vol. 68, pp. 904–910.

  16. 16.

    Kubodera, N., Heterocycles, 2010, vol. 80, pp. 83–98.

  17. 17.

    Li, L., Yue, L., Xue, J., Xie, Z., and Li, Y., Chinese Sci. Bull., 2012, vol. 57, pp. 1616–1619.

  18. 18.

    Pietraszek, A., Malińska, M., Chodyński, M., Krupa, M., Krajewski, K., Cmoch, P., Woźniak, K., and Kutner, A., Steroids, 2013, vol. 78, pp. 1003–1014.

  19. 19.

    Deng, Z., People Rep. China Pat., Faming Zhuanli Shenqing, 2014, vol. CN 103896817.

  20. 20.

    Li, Y., Xue, J., Zhang, X. and Xu, S., Peope Rep. China Pat., Faming Zhuanli Shenqing, 2010, vol. CN 101880253.

  21. 21.

    Bader, T., Stutz, A., Bichsel, H.-U., and Fu, C., Universitat Zurich Pat., PCT Int. Appl. no. WO 2010009879, 2010.

  22. 22.

    Chodynski, M., Krupa, M., Krajewski, K., Kubiszewski, M., Kutner, A., Pietraszek, A., and Trzcinska, K., PCT Int. Appl., no. WO 2011016739, 2010.

  23. 23.

    Kutner, A., Perlman, K. L., Lago, A., Schnoes, H.K., DeLuca, H.F., and Sicinski, R.R., J. Org. Chem., 1988, vol. 53, pp. 3450–3457.

  24. 24.

    Lu, Q., Feng, H., Wen, P., Sun, B., Wan, Y., and Zhou, A., People Rep. China Pat no. CN 102392053, Faming Zhuanli Shenqing, 2012.

  25. 25.

    Fujii, Y. and Tamura, T., PCT Int. Appl. no. WO 2007138894, 2007.

  26. 26.

    Machida, K., Ito, S. F., Yoshikazu, Hirosue, S., and Arisawa, A., PCT Int. Appl. no. WO 2008096695, 2008.

  27. 27.

    Song, W.-Q., Wang, Y.-H., Liu, D.-N., Fang, W.-Z., and Lu, Q., Russ. J. Gen. Chem., 2016, vol. 86, pp. 173–177.

  28. 28.

    Wan, Y., Wen, P., Zhang, P., and Lu, Q., Chin. J. Org. Chem., 2012, vol. 32, pp. 1988–1992.

  29. 29.

    Paaren, H.E., DeLuca, H.F., and Schnoes, H.K., J. Org. Chem., 1980, vol. 45, pp. 3253–3258.

  30. 30.

    Perlman, K.L., Sicinski R.R., Schnoes, H.K., and DeLuca, H.F., Tetrahedron Lett., 1990, vol. 31, pp. 1823–1824.

  31. 31.

    Ding, J., Guo, X., Zeng, Z., and Liu, N., Synlett. 2013, vol. 24, pp. 2606–2608.

Download references

Author information

Correspondence to W. Z. Fang or Q. Lu.

Additional information

The article is published in the original.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Luo, J.Q., Jiang, F., Song, W.Q. et al. Synthesis of paricalcitol: A novel strategy combining chemical and microbial transformations. Russ J Bioorg Chem 43, 323–327 (2017). https://doi.org/10.1134/S1068162017030104

Download citation

Keywords

  • paricalcitol
  • vitamin D2
  • microbial transformation
  • chemical synthesis